Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126968331 | 12696833 | 1 | I | 20160130 | 0 | 20160829 | 20160829 | DIR | 52.00 | YR | F | N | 140.00000 | LBS | 20160826 | N | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126968331 | 12696833 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 7 TABLET TWICE A DAY | N | D | 0 | 7 | DF | COATED TABLET | BID | ||||
126968331 | 12696833 | 3 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
126968331 | 12696833 | 5 | C | GENERIC K-DUR | 2 | 0 | |||||||||||||
126968331 | 12696833 | 7 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
126968331 | 12696833 | 9 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
126968331 | 12696833 | 11 | C | VITAMIN K | PHYTONADIONE | 1 | 0 | ||||||||||||
126968331 | 12696833 | 13 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
126968331 | 12696833 | 15 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
126968331 | 12696833 | 17 | C | PEPCID | FAMOTIDINE | 1 | 0 | ||||||||||||
126968331 | 12696833 | 19 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
126968331 | 12696833 | 21 | C | DIGESTIVE ENZYMES | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
126968331 | 12696833 | 23 | C | INOSITOL | INOSITOL | 1 | 0 | ||||||||||||
126968331 | 12696833 | 25 | C | D-MANNOSE | 2 | 0 | |||||||||||||
126968331 | 12696833 | 27 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
126968331 | 12696833 | 29 | C | FISH OIL | FISH OIL | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126968331 | 12696833 | 1 | Urinary tract infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126968331 | 12696833 | HO |
126968331 | 12696833 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126968331 | 12696833 | Abdominal pain upper | |
126968331 | 12696833 | Amnesia | |
126968331 | 12696833 | Anxiety | |
126968331 | 12696833 | Back disorder | |
126968331 | 12696833 | Bladder disorder | |
126968331 | 12696833 | Cardiac disorder | |
126968331 | 12696833 | Decreased appetite | |
126968331 | 12696833 | Depersonalisation/derealisation disorder | |
126968331 | 12696833 | Depression | |
126968331 | 12696833 | Dizziness | |
126968331 | 12696833 | Dry eye | |
126968331 | 12696833 | Dry mouth | |
126968331 | 12696833 | Dyspnoea | |
126968331 | 12696833 | Dysstasia | |
126968331 | 12696833 | Feeling abnormal | |
126968331 | 12696833 | Gait disturbance | |
126968331 | 12696833 | Gastrointestinal disorder | |
126968331 | 12696833 | Headache | |
126968331 | 12696833 | Hyperhidrosis | |
126968331 | 12696833 | Muscular weakness | |
126968331 | 12696833 | Nausea | |
126968331 | 12696833 | Nervous system disorder | |
126968331 | 12696833 | Nonspecific reaction | |
126968331 | 12696833 | Pain | |
126968331 | 12696833 | Panic attack | |
126968331 | 12696833 | Paraesthesia | |
126968331 | 12696833 | Pyrexia | |
126968331 | 12696833 | Renal disorder | |
126968331 | 12696833 | Syncope | |
126968331 | 12696833 | Tinnitus | |
126968331 | 12696833 | Toxicity to various agents | |
126968331 | 12696833 | Tremor | |
126968331 | 12696833 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126968331 | 12696833 | 1 | 20151019 | 20151025 | 0 |